BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 2500613)

  • 21. Asymptomatic immunoglobulin light chain amyloidosis (AL) at the time of diagnostic bone marrow biopsy in newly diagnosed patients with multiple myeloma and smoldering myeloma. A series of 144 cases and a review of the literature.
    Siragusa S; Morice W; Gertz MA; Kyle RA; Greipp PR; Lust JA; Witzig TE; Lacy MQ; Zeldenrust SR; Rajkumar SV; Russell SJ; Hayman SR; Buadi F; Kumar SK; Dingli D; Dispenzieri A
    Ann Hematol; 2011 Jan; 90(1):101-6. PubMed ID: 20645101
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Exclusively vascular systemic amyloidosis with visceral ischemia.
    Jennette JC; Sheps DS; McNeill DD
    Arch Pathol Lab Med; 1982 Jul; 106(7):323-7. PubMed ID: 6896444
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A case of light chain (AL) amyloidosis associated with IgD multiple myeloma (MM): clinical features, laboratory findings and outcome.
    Rizzi R; Miccolis R; Rinaldi E; Bonerba B; Rossini M; Manno C; Curci P; Specchia G; Liso V
    Amyloid; 2011 Jun; 18 Suppl 1():117-8. PubMed ID: 21838455
    [No Abstract]   [Full Text] [Related]  

  • 24. Development of systemic lambda-light chain amyloidosis in a patient with gamma-heavy chain deposition disease during long-term follow-up.
    Komatsuda A; Maki N; Wakui H; Ohtani H; Hatakeyama T; Yasuda T; Nakamoto Y; Imai H; Sawada K
    Nephrol Dial Transplant; 2005 Feb; 20(2):434-7. PubMed ID: 15673693
    [No Abstract]   [Full Text] [Related]  

  • 25. [Primary amyloidosis associated with multiple myeloma and renal failure: case report].
    Peña O C; Intriago B M; Gray H AM; Cabrera C ME
    Rev Med Chil; 2011 Nov; 139(11):1471-4. PubMed ID: 22446653
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Light chain myeloma presenting as severe obstructive jaundice due to hepatic amyloidosis.
    Segev A; Manor Y; Bernheim J; Mekori YA
    Eur J Haematol; 1999 Nov; 63(5):364-5. PubMed ID: 10580572
    [No Abstract]   [Full Text] [Related]  

  • 27. Primary (AL) amyloidosis in plasma cell disorders.
    Müller AM; Geibel A; Neumann HP; Kühnemund A; Schmitt-Gräff A; Böhm J; Engelhardt M
    Oncologist; 2006; 11(7):824-30. PubMed ID: 16880241
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunoglobulin light and heavy chain amyloidosis AL/AH: renal pathology and differential diagnosis.
    Picken MM
    Contrib Nephrol; 2007; 153():135-55. PubMed ID: 17075228
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Systemic amyloid arthropathy associated with multiple myeloma.
    Kurashima C; Hirokawa K; Kato K; Shimada H; Esaki Y; Miwa T; Mori M
    Acta Pathol Jpn; 1987 May; 37(5):853-61. PubMed ID: 3115058
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Case report: multiple myeloma presenting as a diastolic heart failure with no evidence of amyloidosis.
    Schattner A; Epstein M; Berrebi A; Caspi A
    Am J Med Sci; 1995 Dec; 310(6):256-7. PubMed ID: 7503107
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Monoclonal immunoglobulin deposition disease: light chain and light and heavy chain deposition diseases and their relation to light chain amyloidosis. Clinical features, immunopathology, and molecular analysis.
    Buxbaum JN; Chuba JV; Hellman GC; Solomon A; Gallo GR
    Ann Intern Med; 1990 Mar; 112(6):455-64. PubMed ID: 2106817
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [A rare case of cholestasis and macrohematuria in a 52-year-old patient].
    Arkenau HT; Widjaja A
    Med Klin (Munich); 2002 Aug; 97(8):480-3. PubMed ID: 12229247
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Light chain cardiomyopathy. Structural analysis of the light chain tissue deposits.
    Gallo G; Goñi F; Boctor F; Vidal R; Kumar A; Stevens FJ; Frangione B; Ghiso J
    Am J Pathol; 1996 May; 148(5):1397-406. PubMed ID: 8623912
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An unusual case of amyloidosis complicating light chain myeloma.
    Handa SI; Sheehan T; Ludlam CA
    Acta Haematol; 1991; 86(1):40-1. PubMed ID: 1950361
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Systemic kappa light-chain deposition. An ultrastructural and immunohistochemical study.
    Linder J; Croker BP; Vollmer RT; Shelburne J
    Am J Surg Pathol; 1983 Jan; 7(1):85-93. PubMed ID: 6402947
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of systemic light-chain deposition disease and amyloidosis: a report of three patients with renal involvement.
    Jacquot C; Saint-Andre JP; Touchard G; Nochy D; D'Auzac de Lamartinie C; Oriol R; Druet P; Bariety J
    Clin Nephrol; 1985 Aug; 24(2):93-8. PubMed ID: 3930115
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Complete remission of nephrotic syndrome and improvement of renal function in a patient with light chain deposition disease following high dose chemotherapy with transplantation of autologous haematopoietic stem cells. A case study and review of literature].
    Adam Z; Krejcí M; Pour L; Stepánková S; Cermáková Z; Voska L; Teplan V; Krivanová A; Hájek R; Mayer J
    Vnitr Lek; 2009 Nov; 55(11):1089-96. PubMed ID: 20017442
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Systemic lambda light-chain deposition in a patient with myeloma.
    Ganeval D; Noël LH; Droz D; Leibowitch J
    Br Med J (Clin Res Ed); 1981 Feb; 282(6265):681-3. PubMed ID: 6781614
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An autopsy case of diffuse myelomatosis associated with systemic kappa light chain deposition disease (LCDD). A patho-anatomical, immunohistochemical and immunobiochemical study.
    Toyoda M; Kajita A; Kita S; Osamura Y; Shinoda T
    Acta Pathol Jpn; 1988 Apr; 38(4):479-88. PubMed ID: 3135702
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Cardiomyopathy in plasmacytoma-associated light-chain deposition disease].
    von Herbay A; Mall G; Waldherr R
    Pathologe; 1989 Jul; 10(4):257-60. PubMed ID: 2528128
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.